Health Condition 1: C22- Malignant neoplasm of liver and intrahepatic bile ducts Health Condition 2: C25- Malignant neoplasm of pancreas Health Condition 3: C73- Malignant neoplasm of thyroid gland Health Condition 4: C45-C49- Malignant neoplasms of mesothelial and soft tissue Health Condition 5: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: All patients who underwent and will undergo Irreversible Electroporation procedure from 1st January 2020
Exclusion criteria
Exclusion criteria: Patient who refuse to consent in the prospective group of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To describe adverse events during Irreversible Electroporation at our centre- Tata memorial hospital, MumbaiTimepoint: 24 hours from start of the procedure (From induction of anaesthesia till end of IRE procedure and immediate postoperative) | — |
Secondary
| Measure | Time frame |
|---|---|
| Interference of IRE on Electrocardiography monitoringTimepoint: 24hours from start of procedure (induction of anaesthesia);Effect of electrical pulses on Bispectral Index monitoringTimepoint: 24 hours from start of procedure (induction of anaesthesia);Intraoperative & postoperative requirement of pain killers & the factors affecting the same (for example, age, sex)Timepoint: From Start of procedure till 1 week of postoperative period;The benefits of a Departmental protocol in reducing the intraoperative & postoperative adverse eventsTimepoint: 24 hours from start of procedure (induction of anaesthesia) | — |
Countries
India
Contacts
Public ContactDr Saptashwa Mitra
Tata Memorial Hospital
Outcome results
None listed